Page Title
Clinical Trial Finder
Ask About Participating in This Study
Mucociliary ClearanceCompleted with Results
BALANCE-CF 1: Study of BI 1265162, a mucus clearance drug, in teens and adults with CF, protocol number BI-1399-0003The following information will be used to determine eligibility for this study. Fill out the form and click “Preview Message.” This will draft an email you can send directly to the Research Coordinator. Please note, this does not guarantee entry into this particular study.
* indicates required field
Personal Information
Add more details about who you are and how you would like to be contacted (e.g. phone, text, email).
(this will open in your email program)
Mucociliary ClearanceCompleted with Results
BALANCE-CF 1: Study of BI 1265162, a mucus clearance drug, in teens and adults with CF, protocol number BI-1399-0003
This study evaluated the safety and effectiveness of BI 1265162, a drug intended to improve the clearance of mucus from the lungs.
-
Age:
12 Years and Older
-
Mutation(s):
No Mutation Requirement
-
FEV1% Predicted:
40 to 90%
-
Number of Visits:
5
-
Length of Participation:
7 weeks
Related Topics
Sign up for clinical trial alerts
Get email updates about clinical trials that matter to you.
Check the Drug Development Pipeline
We’re attacking CF from every angle. Learn about the status of CF drugs in development.
Learn More